Insulin-Like Growth Factor 2 mRNA Binding Protein 2 (IGF2BP2) Peptide
-
- Target See all IGF2BP2 products
- IGF2BP2 (Insulin-Like Growth Factor 2 mRNA Binding Protein 2 (IGF2BP2))
- Origin
- Human, Dog, Mouse
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunogen (Imm)
- Sequence
- KQQEQKYPQG VASQR
- Characteristics
- The peptide was used in the production of ABIN369348 - Goat Anti-IGF2BP2 Antibody. It is currently untested in blocking applications.
-
-
- Application Notes
- When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Storage
- -20 °C
- Storage Comment
- Shipped at ambient temperature, store at -20°C.
-
- Target
- IGF2BP2 (Insulin-Like Growth Factor 2 mRNA Binding Protein 2 (IGF2BP2))
- Synonyms
- IMP-2 Peptide, IMP2 Peptide, VICKZ2 Peptide, p62 Peptide, C330012H03Rik Peptide, Imp2 Peptide, Neilsen Peptide, RGD1305614 Peptide, insulin like growth factor 2 mRNA binding protein 2 Peptide, insulin-like growth factor 2 mRNA binding protein 2 Peptide, IGF2BP2 Peptide, Igf2bp2 Peptide
-